How Plantago ovata husk retains water, alters stool consistency, and participates in bile acid metabolism. We analyze human studies on constipation, IBS, LDL, glucose, and satiety, distinguishing clinical results from laboratory mechanisms. We explain dosing, gradual introduction, drug interactions, and safety guidelines.
How composition and processing of cocoa change flavanol dosage, and how the gut and liver modify their chemical form. We analyze the endothelium and nitric oxide, the findings of FLAVIOLA and COSMOS, memory studies, and clinical limitations. We explain EFSA claim conditions, label reading, methylxanthines, and batch quality.
Why fresh garlic, powder, oil, and aged extract are not interchangeable. We explain the formation of allicin, the hydrogen sulfide hypothesis of vascular effects, and human studies on blood pressure, lipids, glucose, immune outcomes, and stomach cancer. We detail bleeding risks, surgery, drug interactions, chemical burns, and storing garlic in oil.
From pungent gingerols and shogaols to human trials on nausea, pain, and glycemic control. We explain the metabolism of components, 5-HT3 and NF-κB signaling, differences between powders and extracts, and clinical effect sizes. We provide a detailed analysis of pregnancy, severe vomiting, menstrual pain, drug interactions, and tolerability.
How epigallocatechin-3-gallate (EGCG) passes through the gut and changes in the body, how tea differs from extracts, and why laboratory mechanisms do not equate to clinical benefits. We analyze studies on energy expenditure, weight, lipids, glucose, oncology, and neurology with doses and effect sizes. We provide detailed information on liver injury, drug interactions, and the boundaries of independent use.
Polyphenols are a diverse group of plant compounds, not a single antioxidant drug. This overview explains their metabolism and microbiota, Nrf2 and the limits of cellular mechanisms, and research on vascular health, cocoa, berries, and resveratrol. We specifically address negative clinical outcomes, risks of concentrated catechins, and practical dietary choices.
How choline participates in membrane structure, VLDL secretion, and one-carbon metabolism. We analyze human deficiency experiments, US AIs, pregnancy and memory research, TMAO metabolism, kidney function, and supplement safety. The necessity of the nutrient is separated from claims of therapeutic effects and cognitive enhancement.
Why inositol is not a true vitamin B8 and how myo-inositol, D-chiro-inositol, IP6, and pinitol differ. From phosphoinositides and insulin signals to studies on PCOS, fertility, pregnancy, and mood: forms, doses, timelines, clinical outcomes, and practical decisions regarding supplementation.
How vitamin B7 supports metabolism and why biotinidase enables its recycling. We examine rare deficiency, dietary references, evidence for hair and nails, 5–10 mg studies, and how laboratory errors depend on specific methods. We explain safe preparation for lab tests without universal washout periods and the priority of emergency medical care.
